These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5378711)

  • 21. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
    Yazdanpanah MJ; Azizi H; Suizi B
    Mycoses; 2007 Jul; 50(4):311-3. PubMed ID: 17576325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pityriasis versicolor. 5 years' material].
    Schonning L; Nyfors A
    Ugeskr Laeger; 1968 May; 130(18):771-3. PubMed ID: 5687420
    [No Abstract]   [Full Text] [Related]  

  • 23. Pityriasis versicolor.
    Faergemann J
    Semin Dermatol; 1993 Dec; 12(4):276-9. PubMed ID: 8312142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study with Hoe 296 in glabrous skin dermatophytosis and pityriasis versicolor].
    González-Ochoa A; Sarmiento-Cristóbal J; Ortega-Llamas O
    Rev Invest Salud Publica; 1974; 34(4):175-81. PubMed ID: 4617272
    [No Abstract]   [Full Text] [Related]  

  • 25. Ketoconazole for the treatment of tinea versicolor.
    Goodless DR
    Int J Dermatol; 1998 Jan; 37(1):77. PubMed ID: 9522248
    [No Abstract]   [Full Text] [Related]  

  • 26. [Local treatment of dermatomycoses with tolnaftate].
    Schmid AH
    Med Klin; 1966 Aug; 61(34):1338 passim. PubMed ID: 5995197
    [No Abstract]   [Full Text] [Related]  

  • 27. Pityriasis versicolor atrophicans.
    Tellechea O; Cravo M; Brinca A; Robalo-Cordeiro M
    Eur J Dermatol; 2012; 22(2):287-8. PubMed ID: 22361878
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of therapeutic effectiveness with tolciclate and miconazole in superficial dermatophytosis and in pityriasis versicolor (author's transl)].
    Wiedey K; Renovanz HD; Maier-Lenz H
    Mykosen; 1982 Mar; 25(3):126-32. PubMed ID: 7045655
    [No Abstract]   [Full Text] [Related]  

  • 29. An open, multicentre assessment of the effectiveness of bifonazole in the treatment of tinea (pityriasis) versicolor.
    Galimberti R; Belli L; Gatti JC; Negroni R; Vignale R
    Pharmatherapeutica; 1985; 4(2):109-12. PubMed ID: 4059290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Local therapy of pityriasis versicolor: antimycotic agent or shampoo?].
    Reinel D
    Mykosen; 1985 May; 28(5):225-31. PubMed ID: 3892288
    [No Abstract]   [Full Text] [Related]  

  • 31. How I treat tinea versicolor.
    Goldyne ME
    Med Times; 1980 Aug; 108(8):42-3, 47. PubMed ID: 7402002
    [No Abstract]   [Full Text] [Related]  

  • 32. Co-localization of Pityriasis versicolor and BT Hansen's disease.
    Narang T; Dogra S; Kaur I
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):206-7. PubMed ID: 16830643
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ketoconazole foaming gel in tinea versicolor (report of 60 cases)].
    el Euch D; Riahi I; Mokni M; Ben Osman A; Mezlini S; Abidi H
    Tunis Med; 1999 Jan; 77(1):38-40. PubMed ID: 10333696
    [No Abstract]   [Full Text] [Related]  

  • 34. The efficacy of oral treatment with pramiconazole in pityriasis versicolor: a phase II a trial.
    Faergemann J; Ausma J; Vandeplassche L; Borgers M
    Br J Dermatol; 2007 Jun; 156(6):1385-8. PubMed ID: 17535237
    [No Abstract]   [Full Text] [Related]  

  • 35. Guidelines of care for superficial mycotic infections of the skin: Pityriasis (tinea) versicolor. Guidelines/Outcomes Committee. American Academy of Dermatology.
    Drake LA; Dinehart SM; Farmer ER; Goltz RW; Graham GF; Hordinsky MK; Lewis CW; Pariser DM; Skouge JW; Webster SB; Whitaker DC; Butler B; Lowery BJ; Elewski BE; Elgart ML; Jacobs PH; Lesher JL; Scher RK
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):287-9. PubMed ID: 8642095
    [No Abstract]   [Full Text] [Related]  

  • 36. Tinea versicolor.
    Lewis MR
    Nurse Pract; 1986 Feb; 11(2):30-1, 35. PubMed ID: 3945418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ciclopiroxolamine in the treatment of pityriasis versicolor].
    Trevisan G; Briscik E
    G Ital Dermatol Venereol; 1988; 123(7-8):XXXIII-XXXV. PubMed ID: 3224994
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor.
    Köse O; Bülent Taştan H; Riza Gür A; Kurumlu Z
    J Dermatolog Treat; 2002 Jun; 13(2):77-9. PubMed ID: 12060506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tinea versicolor: understanding effective treatment options.
    Nevas J
    Nurse Pract; 2012 Jan; 37(1):11-3. PubMed ID: 22217660
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the clinical aspects and therapy of pityriasis versicolor].
    Savinykh MN
    Vestn Dermatol Venerol; 1966 Aug; 40(8):30-3. PubMed ID: 5993743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.